The use of the Airdrive* machine perfusion system in graft preservation during kidney transplantation: a pilot study in kidney transplantation of grafts from post-mortem donors.

The use of the Airdrive* machine perfusion system in graft preservation during kidney transplantation: a pilot study in kidney transplantation of grafts from post-mortem donors. - Airdrive*

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42777

Enrollment

Registered

2016-01-19

Start date

2016-07-06

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney transplantation for kidney failure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients eligble for kidney transplantation from a post-mortem donor, who are at least 18 years of age and mentally competent.

Exclusion criteria

Exclusion criteria: Patient is mentally incompetent and/or has an age of 17 or less. The time between arrival of the graft in the AMC and the transplantation into the patient is expected to be less than 2 hours, as estimated by the transplant surgeon or surgical resident.

Design outcomes

Primary

Measure	Time frame
The main study endpoint is the absence of adverse effects due to the use of Airdrive* machine perfusion as preservation method. Every unexpected event possibly related to the use of the Airdrive* that occurs during the transplantation procedure or within 1-month follow-up, will be evaluated (perioperative cardiovascular incidents, haematological abnormalities, postoperative infections and clinical parameters).	—

Measure

Time frame

The main study endpoint is the absence of adverse effects due to the use of Airdrive* machine perfusion as preservation method. Every unexpected event possibly related to the use of the Airdrive* that occurs during the transplantation procedure or within 1-month follow-up, will be evaluated (perioperative cardiovascular incidents, haematological abnormalities, postoperative infections and clinical parameters).

—

Secondary

Measure	Time frame
Secondary endpoints comprise perfusion parameters, which are recorded as part of the Airdrive* system.	—

Countries

Netherlands

Outcome results